levonorgestrel has been researched along with Body Weight in 92 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (29.35) | 18.7374 |
1990's | 27 (29.35) | 18.2507 |
2000's | 15 (16.30) | 29.6817 |
2010's | 21 (22.83) | 24.3611 |
2020's | 2 (2.17) | 2.80 |
Authors | Studies |
---|---|
Adeyanju, OA; Olatunji, LA | 1 |
Apter, D; Bitzer, J; Höchel, J; Hofmann, BM; Merz, M; Reinecke, I; Serrani, M | 1 |
Adeyanju, OA; Olatunji, LA; Soetan, OA; Soladoye, AO | 1 |
Cartault, A; Pienkowski, C | 1 |
Kardos, L; Luczai, E; Magyar, G; Schváb, E | 1 |
Cleland, K; Smith, NK; Trussell, J; Wagner, B | 1 |
Chen, M; Edelman, A; Helmerhorst, FM; Lopez, LM; Otterness, C; Trussell, J | 1 |
Cleland, K; Wood, S | 1 |
Abitbol, JL; Gainer, E; Guillard, H; Kapp, N; Mathé, H; Scherrer, B; Ulmann, A | 1 |
Kohn, JE; Lopez, PM; Simons, HR | 1 |
Vogel, L | 1 |
Diedrich, JT; Drey, EA; Harper, CC; Sokoloff, A; Steinauer, JE; Upadhyay, UD | 1 |
Gemzell-Danielsson, K; Kardos, L; von Hertzen, H | 1 |
Cholakian, D; Fader, AN; Gehrig, PA; Hacker, K; Tanner, EJ | 1 |
Jusko, WJ | 1 |
Chen, M; Edelman, A; Helmerhorst, FM; Lopez, LM; Otterness, C; Ramesh, S; Trussell, J | 1 |
Madden, T; Omvig, K; Peipert, JF; Silva Dos Santos, PN | 1 |
Kashanian, M; Shahpourian, F; Zare, O | 1 |
Bulechowsky, M; Cameron, J; Edelman, A; Jensen, JT | 1 |
Chen-Mok, M; Edelman, A; Helmerhorst, FM; Lopez, LM; Trussell, J | 1 |
Hait, HI; Reape, KZ; Westhoff, CL | 1 |
Bahamondes, L; Bahamondes, MV; Dal'Ava, N; de Oliveira Santos, A; Monteiro, I | 1 |
Chen, B; Huang, Y; Xin, X; Yuan, P | 1 |
Berman, N; Clevenger, B; Garcia, R; Gonzalo, IT; Nelson, AL; Swerdloff, RS; Wang, C | 1 |
Ratnam, SS; Singh, K; Viegas, OA | 1 |
Gonzalez-ansorena, R; Rubio-lotvin, B; Ruiz-moreno, JA | 1 |
Lopez, G; Rodriguiz, A | 1 |
Defoort, P; Martens, G; Merchiers, E; Parewijck, W; Thiery, M; Van Kets, H | 1 |
Becker, KA; Emans, SJ; Feldman, HA; Goodman, E; Gordon, CM; Grace, E; Gundberg, CM; LeBoff, MS; Rosen, CJ | 1 |
Taneepanichskul, S; Tantbirojn, P | 1 |
Abraham, S; Luscombe, G; Soo, I | 1 |
Suthipongse, W; Taneepanichskul, S | 1 |
Shittu, O; Sule, S | 1 |
Guardianelli, F; Lello, S; Melis, GB; Paoletti, AM; Sorge, R; Vittori, G | 1 |
Balogun, OR | 1 |
Samsioe, G | 1 |
Ayeni, O; Chalapati, S; Dusitsin, N; Gellen, JJ; Gray, R; Koetsawang, S; Pinol, A; Saibiang, S; Sas, M; Tankeyoon, M | 1 |
Christie, T | 1 |
Haspels, AA | 1 |
Woutersz, TB | 1 |
Casado, ME; Croxatto, HB; Díaz, S; Durán, E; Herreros, C; Juez, G; Miranda, P; Peralta, O; Salvatierra, AM | 2 |
Deville, JL; Dubois, M; Gaspard, UJ | 1 |
Anke, M; Chemnitius, KH; Dettmann, R; Deufrains, J; Furcht, R; Gaida, P; Güttner, J; Hesse, G; Hesse, V; Hillesheim, HG; Hoffmann, H; Holle, K; Horn, U; Keil, E; Klinger, G; Kramp, B; Lemke, H; Merbt, EM; Oettel, M; Robiller, F; Schimmel, I; Selzner, A; Stade, K; Strecke, J; Valentin, U | 1 |
Hillesheim, HG; Hoffmann, H | 1 |
Ahren, T; Akinla, O; Alvarez-Sanchez, F; Brache, V; Brenner, PF; Coutinho, E; Darze, E; Diaz, J; Diaz, S; Fasan, MO; Faundes, A; Gama daSilva, JC; Giwa-Osagie, OF; Jackanicz, TM; Mishell, DR; Nash, HA; Nielsen, NC; Pavez, M; Pyorala, T; Roy, S; Sivin, I; Stern, J; Victor, A; Zausner-Guelman, B | 1 |
Kühl, C; Mølsted-Pedersen, L; Skouby, SO | 1 |
Allonen, H; Diaz, J; Luukkainen, T; Nilsson, CG | 1 |
Noerpramana, NP | 1 |
Hales, HA; Hatasaka, HH; Jones, KP; Mainwaring, R; Peterson, CM; Poulson, AM; Stevenson, K | 1 |
Davis, P; Hendon, A; Kozlowski, KJ; Rickert, VI | 1 |
Berenson, AB; Wiemann, CM | 1 |
Harrison, FN; Laurent, S; Phemister, DA | 1 |
Bachmann, GA; Knuppel, RA; Owens, AG; Pasquale, SA | 1 |
Jiang, X; Li, H; Lin, D; Shen, Q; Zhang, Z | 1 |
Inayatullah, A; Rehan, N; Shamim, N | 1 |
Croxatto, HB | 1 |
Du, M; Gao, Y; Gu, S; He, X; Meng, F; Sivin, I; Wang, P; Wu, S; Ying, L; Zhang, L | 1 |
Anderson, NG; Grubb, GS; Moore, D | 1 |
Amatya, RN; Dunson, TR; Krueger, SL | 1 |
Alvarez, F; Bilhareus, P; Brache, V; Darney, P; Diaz, S; Klaisle, C; Koetsawang, S; Lacarra, M; LaGuardia, K; Lähteenmäki, P; Mishell, DR; Nash, H; Pavez, M; Piya-Anant, M; Ranta, S; Sivin, I; Stern, J; Viegas, OA; Wan, L | 1 |
Kaper, RF; Qian, SZ; Sang, GW; Zheng, HM; Zheng, SR | 1 |
Chaudhary, I; Inayatullah, A; Rehan, N | 1 |
Chen, CH; Chow, LP; Du, MK; Zheng, HM | 1 |
Kübler, W; Nawroth, PP; Salbach, B; Salbach, PB; von Holst, Th | 1 |
Abdalla, K; Alvarez, F; Biswas, A; Brache, V; Campodonico, I; Darney, P; Diaz, S; Holma, P; Kiriwat, O; Mishell, DR; Pasquale, S; Pavez, M; Schechter, J; Sivin, I; Wan, L | 1 |
Archer, DF; Harrison, DD; Lemay, A; Roberts, J; Thiboutot, D; Washenik, K | 1 |
Alvarez, F; Anant, MP; Biswas, A; Brache, V; Darney, P; Diaz, S; Kiriwat, O; Klaisle, C; Mishell, DR; Pavez, M; Ranta, S; Schechter, J; Sivin, I; Wan, L | 1 |
Coney, P; DiGiovanna, JJ; Harrison, DD; Langley, RG; Washenik, K | 1 |
Georgiev, DB; Golbs, S; Goudev, A | 1 |
Bloch, B | 1 |
Dain, MP; Janaud, A; Rouffy, J; Upmalis, D | 1 |
Fakeye, O | 1 |
Ashwell, E; Ball, MJ; Gillmer, MD | 1 |
Christiansen, C; Haarbo, J; Leth-Espensen, P; Stender, S | 1 |
Eneroth, P; Jonsson, B; Landgren, BM | 1 |
Otubu, JA; Towobola, OA; Uguru, VE | 1 |
Andrade, AT; Cuadros, A; Dhall, GI; Ji, G; Khan, T; Koetsawang, S; Kononova, ES; Krishna, U; Rodriquez la Puenta, J; Wyss, R | 1 |
Apelo, R; Osteria, T; Ramos, R; Vilar, E | 1 |
Ratnam, SS; Singh, K; Singh, P; Viegas, OA | 2 |
Amatayakul, K; Bamji, MS; Belsey, MA; Hall, P; Joshi, UM; Parker, RA; Prema, K; Singkamani, R; Virkar, KD; Whitehead, TP | 1 |
Abo-Eloyoun, M; Ahmed, AG; Salah, M; Shaaban, MM | 1 |
Allonen, H; Andersson, K; Batar, I; Haukkamaa, M; Holma, P; Lampe, L; Luukkainen, T; Pyörälä, T; Terho, J; Toivonen, J | 1 |
de Castro, AM; de Castro, ML; Giovanini, ME; Gomes, FM; Koifman, S; Mota, LG; Oliveira, DP; Paes, SJ; Poyares, JA; Vianna, NF | 1 |
Nair, KM; Prasad, KV; Rao, BS; Sivakumar, B | 1 |
Cárdenas, H; Croxatto, HB; Díaz, S; Johansson, ED; Larsson, M; Pavez, M | 1 |
Chaudhury, N; Gupta, AN; Hazra, MN; Hingorani, V; Kochhar, M; Kodkany, BS; Logambal, A; Nanda, UK; Rai Choudhary, G; Raja Ram, P | 1 |
Abdullah, KA; Salem, HT; Shaaban, MM | 1 |
Croxatto, HB; Díaz, S; Herreros, C; Juez, G; Peralta, O | 1 |
8 review(s) available for levonorgestrel and Body Weight
Article | Year |
---|---|
[Contraception for adolescent : CNGOF Contraception guidelines].
Topics: Adolescent; Adolescent Health; Body Height; Body Mass Index; Body Weight; Calcification, Physiologic; Condoms; Contraception; Contraceptives, Oral, Hormonal; Female; France; Health Education; Humans; Levonorgestrel; Male; Papillomavirus Infections; Papillomavirus Vaccines; Pregnancy; Pregnancy, Unplanned; Sex Education; Sexually Transmitted Diseases | 2018 |
Levonorgestrel emergency contraception and bodyweight.
Topics: Body Weight; Contraception, Postcoital; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Obesity; Pregnancy; Pregnancy Rate | 2019 |
Progestin-only contraceptives: effects on weight.
Topics: Body Composition; Body Weight; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Weight Gain | 2013 |
Impact of bodyweight/body mass index on the effectiveness of emergency contraception with levonorgestrel: a pooled-analysis of three randomized controlled trials.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraception, Postcoital; Double-Blind Method; Female; Humans; Levonorgestrel; Middle Aged; Overweight; Pregnancy; Randomized Controlled Trials as Topic; World Health Organization; Young Adult | 2015 |
Clarification of contraceptive drug pharmacokinetics in obesity.
Topics: Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity | 2017 |
Progestin-only contraceptives: effects on weight.
Topics: Adolescent; Adult; Body Composition; Body Weight; Contraceptives, Oral, Hormonal; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Prospective Studies; Retrospective Studies; Weight Gain | 2016 |
Progestin-only contraceptives: effects on weight.
Topics: Body Weight; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Weight Gain | 2011 |
NORPLANT: levonorgestrel-releasing contraceptive implant.
Topics: Body Weight; Drug Implants; Female; Forearm; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Pregnancy | 1993 |
36 trial(s) available for levonorgestrel and Body Weight
Article | Year |
---|---|
Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception.
Topics: Body Mass Index; Body Weight; Contraceptives, Postcoital; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Ireland; Levonorgestrel; Models, Biological; Overweight; Pregnancy; Pregnancy Rate; Pregnancy, Unwanted; Risk; United Kingdom; United States | 2015 |
A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran.
Topics: Adolescent; Adult; Body Weight; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Headache; Humans; Iran; Levonorgestrel; Metrorrhagia; Nausea; Patient Satisfaction | 2010 |
Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Retrospective Studies; Young Adult | 2012 |
Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
Topics: Administration, Cutaneous; Adolescent; Adult; Body Weight; Coitus; Contraception; Contraceptive Agents, Male; Drug Implants; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Levonorgestrel; Luteinizing Hormone; Male; Middle Aged; Sex Hormone-Binding Globulin; Spermatogenesis; Testis; Testosterone | 2002 |
Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial.
Topics: Adipose Tissue; Adolescent; Adult; Alkaline Phosphatase; Anorexia Nervosa; Body Composition; Body Image; Body Weight; Bone Density; Collagen; Collagen Type I; Dehydroepiandrosterone; Energy Intake; Estradiol; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Nutritional Physiological Phenomena; Osteocalcin; Osteoporosis; Peptides | 2002 |
Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Thailand; Uterine Hemorrhage | 2002 |
An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 microg ethinylestradiol and 150 microg levonogestrel/30 microg ethinylestradiol in Thai women.
Topics: Adolescent; Adult; Androstenes; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Thailand | 2004 |
Effects on body weight and body composition of a low-dose oral estroprogestin containing ethinyl estradiol 20 microg plus levonorgestrel 100 microg.
Topics: Blood Glucose; Body Composition; Body Weight; Electric Impedance; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids | 2007 |
Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers.
Topics: Adolescent; Adult; Body Weight; Cholesterol Esters; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Norgestrel; Norpregnenes; Phosphatidylcholines; Triglycerides | 1982 |
Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives.
Topics: Adult; Body Height; Body Weight; Breast Feeding; Child Development; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hungary; Infant; Infant, Newborn; Lactation; Levonorgestrel; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norgestrel; Pregnancy; Thailand | 1984 |
Clinical experience with a low-dose contraceptive agent. European studies.
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Pregnancy; Stereoisomerism | 1983 |
Fertility regulation in nursing women: IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth.
Topics: Adult; Body Weight; Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Growth; Humans; Infant; Lactation; Levonorgestrel; Male; Norgestrel; Pregnancy; Time Factors | 1983 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. II-Subjective and objective measures of effects. An international comparative trial.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hemoglobins; Humans; Levonorgestrel; Norgestrel; Pregnancy; Vagina | 1981 |
Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a nova-T-copper device.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation; Norgestrel; Random Allocation | 1982 |
Use of Norplant contraceptive implants in the immediate postpartum period: safety and tolerance.
Topics: Acne Vulgaris; Adult; Blood Pressure; Body Weight; Female; Headache; Humans; Levonorgestrel; Postpartum Period; Prospective Studies; Uterine Hemorrhage | 1995 |
Progestogen-only contraceptives during lactation: I. Infant growth. World Health Organization Task force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Anthropometry; Body Weight; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand | 1994 |
Irregular bleeding, body mass index and coital frequency in Norplant contraceptive users.
Topics: Adult; Body Mass Index; Body Weight; Coitus; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Prospective Studies | 1994 |
Blood pressure changes and hormonal contraceptives.
Topics: Adult; Blood Pressure; Body Weight; China; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Implants; Estrogens; Female; Humans; Levonorgestrel; Progestins; Prospective Studies; Regression Analysis | 1994 |
Phase III clinical trial with Norplant II (two covered rods): report on five years of use.
Topics: Adolescent; Adult; Body Weight; Drug Implants; Family Characteristics; Female; Follow-Up Studies; Foreign-Body Migration; Humans; Infections; Levonorgestrel; Menstruation Disturbances; Patient Dropouts; Patient Satisfaction; Pregnancy | 1993 |
Effectiveness of Norplant implants through seven years: a large-scale study in China.
Topics: Adult; Age Factors; Body Weight; China; Cohort Studies; Drug Implants; Female; Humans; Levonorgestrel; Life Tables; Pregnancy; Pregnancy Rate; Time Factors | 1995 |
Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Time Factors | 1997 |
A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Desogestrel; Female; Hemoglobins; Humans; Levonorgestrel; Patient Acceptance of Health Care; Progesterone Congeners; Uterine Hemorrhage; Vinyl Compounds | 1999 |
Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy.
Topics: Administration, Cutaneous; Body Mass Index; Body Weight; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Leptin; Levonorgestrel; Middle Aged; Obesity; Postmenopause | 2000 |
Prolonged effectiveness of Norplant(R) capsule implants: a 7-year study.
Topics: Adolescent; Adult; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Proportional Hazards Models; Sterilization, Tubal; Time Factors | 2000 |
A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment.
Topics: Acne Vulgaris; Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Placebos; Surveys and Questionnaires | 2001 |
Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Pregnancy | 2001 |
Effects of the combined hormonal replacement drug estradiol valerate/levonorgestrel on climacteric complaints, endometrium and lipid profile of peri- and postmenopausal women.
Topics: Adult; Blood Pressure; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Climacteric; Drug Combinations; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Lipids; Middle Aged; Postmenopause; Triglycerides | 2001 |
The effect of cyclical administration of levonorgestrel and ethinyloestradiol on blood pressure, body mass, blood glucose and serum triglycerides.
Topics: Adolescent; Adult; Blood Glucose; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Norgestrel; Time Factors; Triglycerides | 1979 |
A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel.
Topics: Adolescent; Adult; Androgens; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Lipids; Norgestrel | 1992 |
Progestagen-only oral contraceptives: comparison of the metabolic effects of levonorgestrel and norethisterone.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factors; Blood Pressure; Body Weight; Factor X; Female; Glucose; Glucose Tolerance Test; Hemoglobins; Humans; Levonorgestrel; Lipid Metabolism; Lipoproteins; Norethindrone; Patient Acceptance of Health Care; Risk Factors | 1991 |
Effects of various IUDs on the composition of cervical mucus.
Topics: Body Weight; Cervix Uteri; Cholesterol; Estradiol; Female; Humans; Immunoglobulin G; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Mucins; Mucus; Progesterone; Serum Albumin | 1991 |
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.
Topics: Administration, Intravaginal; Body Weight; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Norgestrel; Pregnancy | 1990 |
A comparative analysis of three different dose combinations of oral contraceptives.
Topics: Adult; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Menstruation Disturbances; Nausea; Norethindrone; Norgestrel; Patient Compliance; Philippines; Pregnancy | 1989 |
Impact of hormonal contraceptives vis-à-vis non-hormonal factors on the vitamin status of malnourished women in India and Thailand. World Health Organization: Special Programme of Research, Development and Research Training in Human Reproduction. Task For
Topics: Adolescent; Adult; Avitaminosis; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Lactation; Levonorgestrel; Medroxyprogesterone; Norgestrel; Pregnancy; Social Class; Vitamins | 1986 |
Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
Topics: Adult; Blood Pressure; Body Weight; Contraceptive Agents, Female; Female; Hemoglobins; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Random Allocation | 1987 |
Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth.
Topics: Adult; Body Height; Body Weight; Breast Feeding; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Intrauterine Devices; Lactation; Levonorgestrel; Norgestrel; Pregnancy; Stereoisomerism | 1985 |
48 other study(ies) available for levonorgestrel and Body Weight
Article | Year |
---|---|
Drospirenone-containing oral contraceptives do not affect glucose regulation and circulating corticosterone.
Topics: Androstenes; Animals; Blood Glucose; Body Weight; Contraceptives, Oral; Corticosterone; Drug Combinations; Ethinyl Estradiol; Female; Insulin; Insulin-Secreting Cells; Levonorgestrel; Rats | 2019 |
Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration route.
Topics: Body Weight; Contraceptive Agents, Hormonal; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2020 |
Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats.
Topics: Administration, Oral; Animals; Body Weight; Drug Combinations; Eating; Estradiol; Estrogens; Ethinyl Estradiol; Fasting; Female; Glycogen Synthase Kinase 3; Insulin Resistance; Insulin-Secreting Cells; Intra-Abdominal Fat; Levonorgestrel; Mineralocorticoids; Obesity; Rats; Rats, Wistar; Triglycerides | 2018 |
"My BMI is too high for Plan B." A changing population of women seeking ulipristal acetate emergency contraception online.
Topics: Adult; Body Mass Index; Body Weight; Contraception, Postcoital; Contraceptives, Postcoital, Hormonal; Drug Labeling; Female; Humans; Levonorgestrel; Norpregnadienes; Obesity; Pharmaceutical Services, Online; United States | 2020 |
A tale of two label changes.
Topics: Body Weight; Contraception, Postcoital; European Union; Female; Humans; Levonorgestrel; Patient Education as Topic; Product Labeling; United States | 2014 |
Weight and body mass index among female contraceptive clients.
Topics: Adolescent; Adult; Body Mass Index; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Cross-Sectional Studies; Female; Humans; Levonorgestrel; Obesity; Prevalence; United States; Young Adult | 2015 |
Rethink weight limits on morning-after pill.
Topics: Body Mass Index; Body Weight; Canada; Contraceptives, Postcoital; Female; Guideline Adherence; Humans; Levonorgestrel; Pharmacists; Practice Guidelines as Topic; Practice Patterns, Physicians'; Treatment Outcome | 2015 |
Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Topics: Abortion, Induced; Adolescent; Adult; Body Weight; Choice Behavior; Contraception; Contraceptive Agents, Female; Decision Making; Desogestrel; Drug Implants; Educational Status; Female; Humans; Intimate Partner Violence; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Racial Groups; Stress, Psychological; Young Adult | 2015 |
Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer.
Topics: Adult; Body Weight; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progestins; Young Adult | 2016 |
Changes in body composition in women using long-acting reversible contraception.
Topics: Adult; Analysis of Variance; Body Composition; Body Mass Index; Body Weight; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Linear Models; Prospective Studies; Young Adult | 2017 |
Combined oral contraceptives and body weight: do oral contraceptives cause weight gain? A primate model.
Topics: Animals; Basal Metabolism; Body Composition; Body Weight; Contraceptives, Oral, Combined; Energy Intake; Ethinyl Estradiol; Female; Levonorgestrel; Macaca mulatta; Obesity | 2011 |
Body weight and composition in users of levonorgestrel-releasing intrauterine system.
Topics: Abdominal Fat; Absorptiometry, Photon; Adiposity; Adolescent; Adult; Body Composition; Body Mass Index; Body Weight; Brazil; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progestins; Prospective Studies; Weight Gain; Young Adult | 2012 |
Long-term regression of experimental endometriosis in a rat model treated with local application of levonorgestrel-loaded biodegradable microspheres.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Body Weight; Disease Models, Animal; Endometriosis; Female; Humans; Levonorgestrel; Microspheres; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Treatment Outcome | 2012 |
Menstrual changes during Norplant use and return of fertility following Norplant implant removal: the Singapore experience.
Topics: Asia; Asia, Southeastern; Biology; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Disease; Family Planning Services; Follow-Up Studies; Levonorgestrel; Menstruation Disturbances; Patient Acceptance of Health Care; Physiology; Research; Singapore | 1991 |
Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience.
Topics: Americas; Biology; Blood; Blood Pressure; Body Weight; Clinical Laboratory Techniques; Clinical Trials as Topic; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developing Countries; Diagnosis; Disease; Ethinyl Estradiol; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Latin America; Levonorgestrel; Lipids; Menstrual Cycle; Menstruation; Metrorrhagia; Mexico; Norethindrone; North America; Patient Acceptance of Health Care; Physiology; Reproduction; Research; Signs and Symptoms | 1992 |
Prospective experience with a levonorgestrel implant--Norplant.
Topics: Age Factors; Amenorrhea; Americas; Anthropometry; Behavior; Biology; Body Weight; Colombia; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Demography; Developed Countries; Developing Countries; Diagnosis; Disease; Dysmenorrhea; Educational Status; Endocrine System; Evaluation Studies as Topic; Family Planning Services; Fertility; Headache; Hemorrhage; Hormones; Incidence; Latin America; Levonorgestrel; Menstrual Cycle; Menstruation; Menstruation Disturbances; Neurologic Manifestations; Parity; Patient Acceptance of Health Care; Physiology; Population; Population Characteristics; Population Dynamics; Reproduction; Reproductive Control Agents; Research; Research Design; Sexual Behavior; Signs and Symptoms; South America; Statistics as Topic | 1984 |
Gestodene: clinical experience with an innovative progestogen used in a combination oral contraceptive preparation.
Topics: Belgium; Biology; Blood; Blood Pressure; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Data Collection; Developed Countries; Ethinyl Estradiol; Europe; Family Planning Services; Incidence; Levonorgestrel; Menstrual Cycle; Menstruation; Patient Acceptance of Health Care; Physiology; Reproduction; Research; Research Design | 1990 |
Oral contraception and cyclic changes in premenstrual and menstrual experiences.
Topics: Abdominal Pain; Adolescent; Adult; Body Mass Index; Body Weight; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Premenstrual Syndrome; Prospective Studies | 2003 |
Weight changes in clients on hormonal contraceptives in Zaria, Nigeria.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Retrospective Studies; Weight Gain; Weight Loss | 2005 |
Analysis of weight, packed cell volume changes and menstrual pattern in Norplant implant acceptors in Ilorin, Nigeria.
Topics: Adult; Amenorrhea; Body Weight; Contraceptive Agents, Female; Female; Hematocrit; Humans; Levonorgestrel; Menstruation; Nigeria; Prospective Studies | 2007 |
Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
Topics: Body Weight; Cardiovascular Diseases; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism | 1983 |
A new ultra-low-dose combination oral contraceptive.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Stereoisomerism | 1983 |
Fertility regulation in nursing women: V. Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth.
Topics: Adult; Body Weight; Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follow-Up Studies; Growth; Humans; Infant; Lactation; Levonorgestrel; Male; Norgestrel; Pregnancy; Time Factors | 1983 |
Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
Topics: Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Leukorrhea; Levonorgestrel; Menstruation; Nausea; Norgestrel; Uterine Hemorrhage | 1983 |
Long term toxicological studies on the progestin STS 557.
Topics: Animals; Body Weight; Contraceptives, Oral, Combined; Dogs; Eating; Female; Glucose Tolerance Test; Hormones; Levonorgestrel; Male; Nandrolone; Norgestrel; Organ Size; Progesterone Congeners; Rats; Time Factors | 1983 |
Data on acute toxicity of the progestin STS 557.
Topics: Animals; Body Temperature; Body Weight; Contraceptives, Oral, Combined; Drinking; Eating; Female; Lethal Dose 50; Levonorgestrel; Male; Mice; Motor Activity; Nandrolone; Norgestrel; Progesterone Congeners; Rabbits; Species Specificity | 1983 |
Low dosage oral contraception in women with previous gestational diabetes.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Norgestrel; Postpartum Period; Pregnancy; Pregnancy in Diabetics; Prospective Studies | 1982 |
A cohort study of Norplant implant: side-effects and acceptance.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Cohort Studies; Contraceptive Agents, Female; Drug Implants; Female; Humans; Indonesia; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Patient Satisfaction; Pregnancy; Pregnancy Rate; Risk Factors; Surveys and Questionnaires; Uterine Hemorrhage | 1995 |
Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Topics: Administration, Oral; Adolescent; Adult; Apolipoprotein A-I; Bilirubin; Body Weight; Cholesterol; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Injections, Intramuscular; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Menstrual Cycle; Norethindrone; Progestins; Sex Hormone-Binding Globulin; Time Factors; Triglycerides; United States | 1995 |
Adolescents and Norplant: preliminary findings of side effects.
Topics: Adolescent; Adult; Analysis of Variance; Arkansas; Black or African American; Blood Pressure; Body Weight; Chi-Square Distribution; Drug Implants; Female; Humans; Levonorgestrel; Menstruation; Retrospective Studies; Time Factors; White People | 1995 |
Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
Topics: Adolescent; Body Weight; Case-Control Studies; Chi-Square Distribution; Child; Condoms; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Implants; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstruation; Norethindrone; Norgestrel; Regression Analysis | 1995 |
Use of Norplant in Pakistan: two years experience.
Topics: Adult; Body Weight; Drug Implants; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Pakistan; Socioeconomic Factors | 1994 |
Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience.
Topics: Adolescent; Adult; Africa; Asia; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Follow-Up Studies; Humans; Latin America; Levonorgestrel; Life Tables; Menstruation; Pregnancy; Pregnancy Rate | 1995 |
Risk factors for discontinuation of Norplant implant use due to menstrual problems.
Topics: Adult; Body Weight; Drug Implants; Educational Status; Female; Humans; Levonorgestrel; Menorrhagia; Menstruation Disturbances; Pregnancy; Risk Factors; Smoking | 1996 |
Efficacy and continuation rates of Norplant in Pakistan.
Topics: Adult; Age Factors; Body Weight; Contraceptive Agents, Female; Educational Status; Employment; Female; Follow-Up Studies; Humans; Levonorgestrel; Middle Aged; Pakistan; Parity; Patient Satisfaction; Pregnancy; Pregnancy Rate | 1999 |
A 10-year follow-up study of contraceptive Norplant implants.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Device Removal; Drug Implants; Female; Follow-Up Studies; Humans; Levonorgestrel; Menstruation Disturbances | 2000 |
Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Blood Specimen Collection; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy Rate; Regression Analysis; Time Factors | 2001 |
The effect of low-dose oral contraceptives and Norplant on blood pressure and body weight of Nigerian women.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Drug Implants; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Nigeria; Norgestrel; Prospective Studies | 1992 |
Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.
Topics: Animals; Aorta; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Drug Therapy, Combination; Endometrium; Energy Intake; Estradiol; Estradiol Dehydrogenases; Female; Isocitrate Dehydrogenase; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Ovariectomy; Rabbits | 1991 |
Effects of oral contraceptive pills on serum lipoproteins and triglycerides.
Topics: Adult; Blood Pressure; Body Weight; Cholesterol, HDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Regression Analysis; Time Factors; Triglycerides | 1990 |
Norplant contraceptive subdermal implants: two-year experience in Singapore.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Norgestrel; Singapore | 1989 |
Norplant-2 rods contraceptive subdermal implants: two-year experience in Singapore.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Silicone Elastomers; Singapore | 1989 |
Five-year experience with Norplant implants in Assiut, Egypt.
Topics: Adult; Age Factors; Blood Pressure; Body Weight; Egypt; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Norgestrel; Patient Compliance; Pregnancy; Prostheses and Implants; Silicone Elastomers; Uterine Hemorrhage | 1987 |
[Evaluation of the contraceptive agent norplant in the municipality of Rio de Janeiro, RJ (Brazil)].
Topics: Administration, Oral; Adolescent; Adult; Blood Pressure; Body Weight; Evaluation Studies as Topic; Female; Humans; Hypertension; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Norgestrel; Parity; Product Surveillance, Postmarketing | 1987 |
Effect of food-restriction on steady state kinetics and tissue distribution of norethindrone and levonorgestrel in rabbits.
Topics: Animals; Body Weight; Female; Food Deprivation; Levonorgestrel; Metabolic Clearance Rate; Norethindrone; Norgestrel; Organ Size; Rabbits; Tissue Distribution | 1988 |
Clearance of levonorgestrel from the circulation following removal of NORPLANT subdermal implants.
Topics: Adult; Body Composition; Body Weight; Delayed-Action Preparations; Female; Half-Life; Humans; Levonorgestrel; Norgestrel | 1988 |
Phase III-clinical trial with Norplant-2 (covered rods). Report of a 24-month study. National Programme of Research in Human Reproduction. Division of Human Resource Development Research Indian Council of Medical Research Ansari Nagar, New Delhi, India.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy | 1988 |
[Influence of Norplant contraceptive implants on lactation and infant growth].
Topics: Body Weight; Breast Feeding; Female; Growth; Humans; Infant; Infant, Newborn; Intrauterine Devices, Copper; Lactation; Levonorgestrel; Male; Milk, Human; Norgestrel; Pregnancy | 1985 |